Literature DB >> 10999923

Screening for Down's syndrome. Biochemical screening offers advantages.

P A Boyd, M Jefferies, P F Chamberlain, A J Crocker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999923      PMCID: PMC1127874     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

1.  Prenatal screening for Down's syndrome using inhibin-A as a serum marker.

Authors:  N J Wald; J W Densem; L George; S Muttukrishna; P G Knight
Journal:  Prenat Diagn       Date:  1996-02       Impact factor: 3.050

2.  Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989-97.

Authors:  D Mutton; R G Ide; E Alberman
Journal:  BMJ       Date:  1998-10-03

Review 3.  Established markers in second trimester maternal serum.

Authors:  H Cuckle
Journal:  Early Hum Dev       Date:  1996-12-30       Impact factor: 2.079

4.  Maternal serum screening for Down's syndrome in early pregnancy.

Authors:  N J Wald; H S Cuckle; J W Densem; K Nanchahal; P Royston; T Chard; J E Haddow; G J Knight; G E Palomaki; J A Canick
Journal:  BMJ       Date:  1988-10-08

5.  Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.

Authors:  N J Wald; H C Watt; A K Hackshaw
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

6.  Appropriate biochemical parameters in first-trimester screening for Down syndrome.

Authors:  H S Cuckle; J M van Lith
Journal:  Prenat Diagn       Date:  1999-06       Impact factor: 3.050

7.  MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.

Authors:  F S Jørgensen; L Valentin; K A Salvesen; C Jørgensen; F R Jensen; J Bang; S H Eik-Nes; M Madsen; K Marsal; P H Persson; J Philip; J W Bogstad; B Nørgaard-Pedersen
Journal:  Acta Obstet Gynecol Scand       Date:  1999-07       Impact factor: 3.636

8.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.

Authors:  R J Snijders; P Noble; N Sebire; A Souka; K H Nicolaides
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

9.  Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.

Authors:  S F Goodburn; J R Yates; P R Raggatt; C Carr; M E Ferguson-Smith; A J Kershaw; P J Milton; M A Ferguson-Smith
Journal:  Prenat Diagn       Date:  1994-05       Impact factor: 3.050

10.  Four-marker serum screening for Down's syndrome.

Authors:  N J Wald; J W Densem; D Smith; G G Klee
Journal:  Prenat Diagn       Date:  1994-08       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.